Click on headlines below to download research

A matter of time until prime time
e-Therapeutics | 23/04/2018

With the refocusing of the business and the new CEO’s strategic review now implemented, e-Therapeutics (ETX) finds itself with the NDD platform and…

Nearing prime time validation
e-Therapeutics | 05/01/2018

e-Therapeutics’ (ETX) Network-Driven Drug Discovery (NDD) platform has begun to deliver encouraging data that should support out-licensing of its…

Sailing a steady course
e-Therapeutics | 04/10/2017

e-Therapeutics’ (ETX) interim numbers demonstrate tight cost control and focus on the rationalised pipeline, with continued investment into the Network-Driven…